Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands

Oncogene

Volumn 29, Issue 32, 2010, Pages 4599-4610

  Luker, K E ^a   Steele, J M ^a   Mihalko, L A ^a   Ray, P ^a   Luker, G D ^a,b  

^a Center for Molecular Imaging   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

bioluminescence imaging; breast cancer; chemokine receptors; chemokines; luciferase; protein fragment complementation

Indexed keywords

BETA ARRESTIN 2; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CLATHRIN; CXCL11 CHEMOKINE;

ARTICLE; BREAST CANCER; CANCER CELL; CELL SURFACE; CONTROLLED STUDY; ENDOCYTOSIS; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ARRESTINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CHEMOKINE CXCL11; CHEMOKINE CXCL12; CHEMOKINES; CLATHRIN; CYTOSOL; ENDOCYTOSIS; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; LYSOSOMES; PROTEIN TRANSPORT; RECEPTORS, CXCR; RECEPTORS, CXCR4;

EID: 77955657351     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.212     Document Type: Article

References (53)

1. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domerci J, Huang H et al. (2004). Molecular characterization of the tumor micro-environment in breast cancer. Cancer Cell 6: 17-32.
2. Atanackovic D, Cao Y, Kim J, Brandl S, Thorn I, Faltz C et al. (2008). The local cytokine and chemokine milieu within malignant effusions. Tumour Biol 29: 93-104.
3. Balabanian K, Lagane B, Infantino S, Chow K, Harriague J, Moepps B et al. (2005). The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760-35766.
4. Balkwill F. (2004). Cancer and the chemokine network. Nat Rev Cancer 4: 540-550.
5. Boldajipour B, Mahabaleshwar S, Kardash E, Reichman-Fried M, Blaser H, Minina S et al. (2008). Control of chemokine-guided cell migration by ligand sequestration. Cell 132: 463-473.
6. Burns J, Summers B, Wang Y, Melikian A, Berahovich R, Miao Z et al. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203: 2201-2213.
7. Cox J, Dean R, Roberts C, Overall C. (2008). Matrix metalloprotei-nase processing of CXCL11/I-TAC results in loss of chemoattrac-tant activity and altered glycosaminoglycan binding. J Biol Chem 283: 19389-19399.
8. Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N et al. (2005). Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 6: 1038-1046.
9. Fermas S, Gonnet F, Sutton A, Charnaux N, Mulloy B, Du Y et al. (2008). Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. Glycobiology 18: 1054-1064.
10. Furuya M, Suyama T, Usui H, Kasuya Y, Nishiyama M, Tanaka N et al. (2007). Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis. Hum Pathol 37: 1676-1687.
11. Galliera E, Venkatakrishna R, Trent J, Bonecchi R, Signorelli P, Lefkowitz R et al. (2004). b-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 279: 25590-25597.
12. Griesbeck O, Barid G, Campbell R, Zacharias D, Tsien R. (2001). Reducing the environmental sensitivity of yellow fluorescent protein. Mechanism and applications. J Biol Chem 276: 29188-29194.
13. Hansell C, Simpson C, Nibbs R. (2006). Chemokine sequestration by atypical chemokine receptors. Biochem Soc Trans 34: 1009-1013.
14. Heuser J, Anderson R. (1989). Hypertonic media inhibit receptor-mediated but not fluid-phase endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108: 389-400.
15. Hoogewerf A, Kuschert G, Proudfoot A, Borlat F, Clark-Lewis I, Power C et al. (1997). Glycosaminoglycans mediate cell surface oligomerization of chemokine. Biochemistry 36: 13570-13578.
16. Kalatskaya I, Berchiche Y, Gravel S, Limberg B, Rosenbaum J, Heveker N. (2009). AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75: 1240-1247.
17. Kang Y, Siegel P, Shu W, Drobnjak M, Kakonen S, Cordon-Cardo C et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
18. Kelly K, Narhendorf M, Yu A, Reynolds F, Weissleder R. (2006). in vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol 8: 1536-1632.
19. Kohout T, Lin F-T, Perry S, Conner D, Lefkowitz R. (2001). Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA 98: 1601-1606.
20. Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling M et al. (2007). Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 9: 862-870.
21. Laquri C, Sadir R, Rueda P, Baleux F, Gans P, Arenzana-Seisdedos F et al. (2007). The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS One 2: e1110.
22. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B. (2009). CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113: 6085-6093.
23. Lois C, Hong E, Pease S, Brown E, Baltimore D. (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872.
24. Luker G, Pica C, Song J, Luker K, Piwnica-Worms D. (2003). Imaging 26S proteasome activity and inhibition in living mice. Nat Med 9: 969-973.
25. Luker K, Gupta M, Luker G. (2008). Imaging CXCR4 signaling with firefly luciferase complementation. Anal Chem 80: 5565-5573.
26. Luker K, Gupta M, Luker G. (2009a). Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7. Biotechniques 47: 625-632.
27. Luker K, Gupta M, Luker G. (2009b). Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J 23: 823-834.
28. Luker K, Gupta M, Steele J, Foerster B, Luker G. (2009c). Imaging ligand-dependent activation of CXCR7. Neoplasia 11: 1022-1035.
29. Luker K, Luker G. (2006). Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238: 30-41.
30. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839-850.
31. Marchese A, Benovic J. (2001). Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 276: 45509-45512.
32. Miao Z, Luker K, Summers B, Berahovich R, Bhojani M, Rehemtulla A et al. (2007). CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104: 15735-15740.
33. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanon M et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
34. Naumann U, Cameroni E, Pruenster M, Mahabaleshwar S, Raz E, Zerwes H et al. (2010). CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5: e9175.
35. Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
36. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G et al. (2001). Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554-3561.
37. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J et al. (2009). The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 10: 101-108.
38. Raggo C, Ruhl R, McAllister S, Koon H, Dezube B, Fruh K et al. (2005). Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res 65: 5084-5095.
39. Sadir R, Imberty A, Baleux F, Lortat-Jacob H. (2004). Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 279: 43854-43860.
40. Sharma V, Crankshaw C, Piwnica-Worms D. (1996). Effects of multidrug resistance (MDR1) P-glycoprotein expression levels and coordination metal on the cytotoxic potency of multidentate (N4O2) (ethylenediamine)bis[propyl(R- benzylimino)]metal(III) cations. J Med Chem 39: 3483-3490.
41. Shenoy S, Lefkowitz R. (2003). Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375: 503-515.
42. Sierro F, Biben C, Martinez-Munoz L, Mellado M, Rashohoff R, Li M et al. (2007). Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 104: 14759-14764.
43. Smith M, Luker K, Garbow J, Prior J, Jackson E, Piwnica-Worms D et al. (2004). CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612.
44. Strieter R, Burdick M, Mestas J, Gomperts B, Keane M, Belperio J. (2006). Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42: 768-778.
45. van Weert A, Geuze H, Groothuis B, Stoorvogel W. (2000). Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direction intearction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur J Cell Biol 79: 394-399.
46. Vandercappellen J, Van Damme J, Struyf S. (2008). The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226-244.
47. Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta K et al. (2008). The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 283: 4283-4294.
48. Weber M, Blair E, Simpson C, O'Hara M, Blackburn P, Rot A et al. (2004). The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 15: 2492-2508.
49. Wu F, Ou Z, Feng L, Luo J, Wang L, Shen Z et al. (2008). Chemokine decoy receptor d6 plays a negative role in human breast cancer. Mol Cancer Res 6: 1276-1288.
50. Yang X, Chu Y, Wang Y, Guo Q, Xiong S. (2005). Vaccination with IFN-inducible T cell alpha chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells. Vaccine 24: 2966-2974.
51. Zabel B, Wang Y, Lewen S, Berahovich R, Penfold M, Zhang P et al. (2009). Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 183: 3204-3211.
52. Zhang L, Yeger H, Das B, Irwin M, Baruchel S. (2007). Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia 9: 36-46.
53. Zhao M, Mueller B, DiScipio R, Schraufstatter I. (2008). Akt plays an important role in breast cancer cell chemotaxis to CXCL12. Breast Cancer Res Treat 110: 211-222.